Scarica l'app Stockscreener
188.33
0.10%
0.19
Pre-mercato:
188.60
0.27
+0.14%
Ishares Biotechnology Etf Borsa (IBB) Ultime notizie
Arrivent Biopharma Inc (AVBP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biomea Fusion Inc (BMEA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
FBT and IBB Are Not the Same Biotech Bet, and 5 Years of Returns Prove It - 24/7 Wall St.
Sutro Biopharma Inc (STRO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Oruka Therapeutics Inc (ORKA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Anavex Life Sciences Corp (AVXL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alumis Inc (ALMS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
iShares Biotechnology ETF Shs Cert Deposito Arg Repr 0.037037037 Sh Revenue Breakdown – BCBA:IBB.CI - TradingView
Sana Biotechnology Inc (SANA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Altimmune Inc (ALT) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
iShares Global Healthcare ETF vs VanEck Biotech ETF: Which ETF Is Better for Profiting With Healthcare in 2026? - The Motley Fool
Which iShares Healthcare ETF Is the Better Buy: Diversified IXJ or Biotech-Focused IBB? - The Motley Fool
iShares Biotechnology ETF (rIBB) Price Prediction - Bitget
Is the iShares Healthcare ETF or the Invesco Nasdaq Biotech ETF the Better Bet for Investors in 2026? - The Motley Fool
Which Healthcare ETF Is the Better Buy: iShares' Global IXJ or First Trust's Biotech FBT? - The Motley Fool
IXJ vs. IBBQ: Global Healthcare vs. Biotech -- Which ETF Is the Better Buy? - The Globe and Mail
Understanding the Shape of the iShares Biotechnology ETF Portfolio - sekbernews.id
IBB ETF Holds Fewer Bets Than You Think - Trefis
$188.977 | iShares Biotechnology ETF (IBB) Stock Price Today - Binance
Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance? - AOL.com
Should You Invest in the VanEck Biotech ETF (BBH)? - Yahoo Finance
Biotech ETFs: How Do FBT and IBB Match Up on Cost, Structure, and Performance? - The Motley Fool
Healthcare ETFs Face-Off: Stability vs. Biotech Growth, Which Strategy Wins? - finance.biggo.com
5 Best Biotech ETFs for 2026 and How to Invest - The Motley Fool
IHE vs. IBB: Which iShares Healthcare ETF Is the Better Buy? - The Motley Fool
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - Yahoo Finance
iShares NASDAQ Biotechnology ETF declares quarterly distribution of $0.0238 - MSN
Cramer’s mad dash: iShares Biotechnology ETF - MSN
iShares Biotechnology ETF(IBB) Stock Options Chain | Quotes & News - Moomoo
Cramer’s Mad Dash: iShares Biotechnology ETF - CNBC
Vanguard Health Care vs. iShares Biotech: How Do These ETFs Stack Up? - The Motley Fool
IBBiShares Biotechnology ETF Dividends - Finviz
RXRX rallies past biotech ETFs as short interest, insider-sale filings shape coming week - TechStock²
SPDR Health Care ETF Tops iShares Biotech in Long-Term Returns - The Motley Fool
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - Yahoo Finance
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - Yahoo Finance
Healthcare Stocks Got A Late Lift From Big Headlines - Finimize
Greece’s Return and a Chip Meltdown: MSCI World ETF Caught Between Index History and Market Chaos - Ad-hoc-news.de
How Ishares Biotechnology Etf (IBB) Affects Rotational Strategy Timing - Stock Traders Daily
The biotech sector looks ready for a multi-year breakout: Here's what to watch - MSN
The Biotech Sector Looks Ready for a Multi-Year Breakout—Here's What to Watch. - MarketBeat
Biotech ETFs Gain Momentum via AI Drug Discovery & Surging M&A - ETF Database
Biotech's Silent Resurgence (5-Year Base Breakout) - TradingView
Biotech breakout: iShares Biotechnology ETF hits all-time high - Seeking Alpha
Why Is Natera Stock Gaining Tuesday? - Benzinga
Biotech ETFs Put Up Strong Show in 1H 2026: More Gains Ahead? - TradingView
Biotech ETF hits record as AbbVie seals $10.9B Apogee deal - MSN
0.12%
0.30%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):